Corpechot C - Search Results

1

Baveno-VI-Guided Prediction of Esogastric Varices in Primary Biliary Cholangitis.

Pariente A, Chazouilleres O, Causse X, Hanslik B, Arpurt JP, Henrion J, Rosa I, Renou C, Corpechot C; Group of Investigators of DESCRIPT 1 and 2 Studies. Pariente A, et al. Among authors: corpechot c. Am J Gastroenterol. 2019 Feb;114(2):361-362. doi: 10.14309/ajg.0000000000000056. Am J Gastroenterol. 2019. PMID: 30676377 No abstract available.

2

Fetal microchimerism in primary biliary cirrhosis.

Corpechot C, Barbu V, Chazouillères O, Poupon R. Corpechot C, et al. J Hepatol. 2000 Nov;33(5):696-700. doi: 10.1016/s0168-8278(00)80298-6. J Hepatol. 2000. PMID: 11097475

3

Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?

Corpechot C, Benlian P, Barbu V, Chazouillères O, Poupon RE, Poupon R. Corpechot C, et al. J Hepatol. 2001 Sep;35(3):324-8. doi: 10.1016/s0168-8278(01)00137-4. J Hepatol. 2001. PMID: 11592592

4

Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients.

Corpechot C, Carrat F, Poupon R, Poupon RE. Corpechot C, et al. Gastroenterology. 2002 Mar;122(3):652-8. doi: 10.1053/gast.2002.31880. Gastroenterology. 2002. PMID: 11874998

5

[Primary biliary cirrhosis. Primary sclerosing cholangitis].

Corpechot C, Chazouilleres O. Corpechot C, et al. Gastroenterol Clin Biol. 2003 Mar;27(3 Pt 1):325-32. Gastroenterol Clin Biol. 2003. PMID: 12769103 French. No abstract available.

6

The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis.

Corpechot C, Carrat F, Bahr A, Chrétien Y, Poupon RE, Poupon R. Corpechot C, et al. Gastroenterology. 2005 Feb;128(2):297-303. doi: 10.1053/j.gastro.2004.11.009. Gastroenterology. 2005. PMID: 15685541

7

Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC.

Corpechot C, El Naggar A, Poujol-Robert A, Ziol M, Wendum D, Chazouillères O, de Lédinghen V, Dhumeaux D, Marcellin P, Beaugrand M, Poupon R. Corpechot C, et al. Hepatology. 2006 May;43(5):1118-24. doi: 10.1002/hep.21151. Hepatology. 2006. PMID: 16628644

8

Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?

Chazouillères O, Corpechot C. Chazouillères O, et al. Among authors: corpechot c. Nat Clin Pract Gastroenterol Hepatol. 2006 May;3(5):248-9. doi: 10.1038/ncpgasthep0493. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16673001 No abstract available.

9

Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis.

Poupon R, Chazouilleres O, Corpechot C, Chrétien Y. Poupon R, et al. Among authors: corpechot c. Hepatology. 2006 Jul;44(1):85-90. doi: 10.1002/hep.21229. Hepatology. 2006. PMID: 16799997

10

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.

Corpechot C, Abenavoli L, Rabahi N, Chrétien Y, Andréani T, Johanet C, Chazouillères O, Poupon R. Corpechot C, et al. Hepatology. 2008 Sep;48(3):871-7. doi: 10.1002/hep.22428. Hepatology. 2008. PMID: 18752324

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

176 results

Search Page

Filters